These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37061102)

  • 1. CEFTO-CURE study: CEFTObiprole Clinical Use in Real-lifE - a multi-centre experience in Italy.
    Gentile I; Buonomo AR; Corcione S; Paradiso L; Giacobbe DR; Bavaro DF; Tiseo G; Sordella F; Bartoletti M; Palmiero G; Vozza A; Vena A; Canta F; Moriello NS; Congera P; Karruli A; Tascini C; Viale P; Bono VD; Falcone M; Carbonara S; Mikulska MK; Bassetti M; Durante-Mangoni E; De Rosa FG; Maraolo AE
    Int J Antimicrob Agents; 2023 Jul; 62(1):106817. PubMed ID: 37061102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early improvement in severely ill patients with pneumonia treated with ceftobiprole: a retrospective analysis of two major trials.
    Scheeren TWL; Welte T; Saulay M; Engelhardt M; Santerre-Henriksen A; Hamed K
    BMC Infect Dis; 2019 Feb; 19(1):195. PubMed ID: 30808293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumonia.
    Awad SS; Rodriguez AH; Chuang YC; Marjanek Z; Pareigis AJ; Reis G; Scheeren TW; Sánchez AS; Zhou X; Saulay M; Engelhardt M
    Clin Infect Dis; 2014 Jul; 59(1):51-61. PubMed ID: 24723282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftobiprole and pneumonia in adults admitted to the emergency department is it time to assess a new therapeutic algorithm?
    Crapis M; Venturini S; Della Siega P; Tonizzo M; Garlatti E; Rosa R; Basso B; Pontoni E
    J Chemother; 2021 May; 33(3):174-179. PubMed ID: 32996844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic drug evaluation of ceftobiprole for the treatment of MRSA.
    Horn KS; Danziger LH; Rodvold KA; Glowacki RC
    Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):463-472. PubMed ID: 28264613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftobiprole medocaril: a review of its use in patients with hospital- or community-acquired pneumonia.
    Syed YY
    Drugs; 2014 Sep; 74(13):1523-42. PubMed ID: 25117196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftobiprole for the treatment of pneumonia: a European perspective.
    Liapikou A; Cillóniz C; Torres A
    Drug Des Devel Ther; 2015; 9():4565-72. PubMed ID: 26316697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient Populations.
    Torres A; Mouton JW; Pea F
    Clin Pharmacokinet; 2016 Dec; 55(12):1507-1520. PubMed ID: 27272266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefto Real-Life Study: Real-World Data on the Use of Ceftobiprole in a Multicenter Spanish Cohort.
    Hidalgo-Tenorio C; Pitto-Robles I; Arnés García D; de Novales FJM; Morata L; Mendez R; de Pablo OB; López de Medrano VA; Lleti MS; Vizcarra P; Lora-Tamayo J; Arnáiz García A; Núñez LM; Masiá M; Seco MPR; Sadyrbaeva-Dolgova S
    Antibiotics (Basel); 2023 Jul; 12(7):. PubMed ID: 37508314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftobiprole: drug evaluation and place in therapy.
    Giacobbe DR; De Rosa FG; Del Bono V; Grossi PA; Pea F; Petrosillo N; Rossolini GM; Tascini C; Tumbarello M; Viale P; Bassetti M
    Expert Rev Anti Infect Ther; 2019 Sep; 17(9):689-698. PubMed ID: 31553250
    [No Abstract]   [Full Text] [Related]  

  • 11. A Phase 3, Randomized, Investigator-blinded Trial Comparing Ceftobiprole With a Standard-of-care Cephalosporin, With or Without Vancomycin, for the Treatment of Pneumonia in Pediatric Patients.
    Bosheva M; Gujabidze R; Károly É; Nemeth A; Saulay M; Smart JI; Hamed KA
    Pediatr Infect Dis J; 2021 Jun; 40(6):e222-e229. PubMed ID: 33480665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftobiprole: a new broad spectrum cephalosporin.
    El Solh A
    Expert Opin Pharmacother; 2009 Jul; 10(10):1675-86. PubMed ID: 19527192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of ceftobiprole in patients aged 65 years or older: a 
    Welte T; Scheeren TW; Overcash JS; Saulay M; Engelhardt M; Hamed K
    Future Microbiol; 2021 May; 16():543-555. PubMed ID: 33960817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftobiprole medocaril in the treatment of hospital-acquired pneumonia.
    Scheeren TW
    Future Microbiol; 2015; 10(12):1913-28. PubMed ID: 26573022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-World Experience of Ceftobiprole for Community- and Hospital-Acquired Pneumonia from a Stewardship Perspective.
    Corcione S; De Benedetto I; Carlin M; Pivetta EE; Scabini S; Grosso C; Shbaklo N; Porta M; Lupia E; De Rosa FG
    Microorganisms; 2024 Apr; 12(4):. PubMed ID: 38674669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcus aureus from hospital-acquired pneumonia from an Italian nationwide survey: activity of ceftobiprole and other anti-staphylococcal agents, and molecular epidemiology of methicillin-resistant isolates.
    Antonelli A; Giani T; Coppi M; Di Pilato V; Arena F; Colavecchio OL; Conte V; Santerre Henriksen A; Rossolini GM;
    J Antimicrob Chemother; 2019 Dec; 74(12):3453-3461. PubMed ID: 31652323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and Future Considerations for the Treatment of Hospital-Acquired Pneumonia.
    Montravers P; Harpan A; Guivarch E
    Adv Ther; 2016 Feb; 33(2):151-66. PubMed ID: 26861846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftobiprole for the treatment of pneumonia.
    Cillóniz C; Dominedò C; Garcia-Vidal C; Torres A
    Rev Esp Quimioter; 2019 Sep; 32 Suppl 3(Suppl 3):17-23. PubMed ID: 31364337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A
    Huang H; Gao L; Engelhardt M; Saulay M; Hamed K
    Future Microbiol; 2021 Jul; 16():783-796. PubMed ID: 34155899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-life experience with ceftobiprole in a tertiary-care hospital.
    Durante-Mangoni E; Andini R; Mazza MC; Sangiovanni F; Bertolino L; Ursi MP; Paradiso L; Karruli A; Esposito C; Murino P; Corcione A; Zampino R
    J Glob Antimicrob Resist; 2020 Sep; 22():386-390. PubMed ID: 32247081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.